National media: Report questions expanded Ohio inmate electronic...
January 22, 2020
Article has no nextliveshere tags assigned
Article has no topics tags assigned
Article has no colleges tags assigned
Description is empty
Article has no audiences tags assigned
Article has no units tags assigned
Contacts are empty
These messages will display in edit mode only.
A journalist for Healthline spoke with Loren Brook, MD, an assistant professor in the UC Department of Internal Medicine, about possible treatments for inflammatory bowel disease (IBD). In 2015, more than 3 million U.S. adults reported a diagnosis of IBD, an ongoing inflammation of all or part of the digestive tract, and includes two conditions, Crohn’s Disease and ulcerative colitis.
Brook, also a UC Health physician, explained the disease is usually lifelong but can be managed with relatively minor anti-inflammatory drugs such as oral mesalamine to immune-suppressing medications such as Remicade or steroids.